AATec Medical and Northway Biotech Announce Partnership to Develop Industrial Production Process for ATL-105 Targeting Lung Diseases

· Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin · Lead indication is non-CF bronchiectasis; ATL-105 targe